ADMA Biologics (ADMA) Shareholder Alert: Kehoe Law Firm Investigates Potential Fiduciary Duty Breaches
Kehoe Law Firm, P.C. is investigating potential fiduciary duty breaches by officers and directors of ADMA Biologics concerning the company's reported growth, distribution practices, and corporate oversight. The investigation references a March 2026 report by short seller Culper Research alleging channel stuffing, as well as ADMA's May 2026 disclosure regarding increased competition and inventory levels affecting its BIVIGAM product.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.